Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
Fadnes LT, Aas CF, Vold JH, Ohldieck C, Leiva RA, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA; INTRO-HCV Study Group. Fadnes LT, et al. Among authors: leiva ra. BMC Infect Dis. 2019 Nov 8;19(1):943. doi: 10.1186/s12879-019-4598-7. BMC Infect Dis. 2019. PMID: 31703669 Free PMC article. Clinical Trial.
The impact of age on risk assessment, therapeutic practice and outcome in candidemia.
Hesstvedt L, Gaustad P, Müller F, Torp Andersen C, Brunborg C, Mylvaganam H, Leiva RA, Berdal JE, Egil Ranheim T, Johnsen BO, Falch BM, Grimnes G, Skogen V, Haarr E, Sandmo Lyngøy A, Wik Larssen K, Hannula R, Åsheim Hansen B, Nordøy I; Norwegian Fungal Network. Hesstvedt L, et al. Among authors: leiva ra. Infect Dis (Lond). 2019 Jun;51(6):425-434. doi: 10.1080/23744235.2019.1595709. Epub 2019 Apr 23. Infect Dis (Lond). 2019. PMID: 31010380
Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway.
Lygren OJ, Bjørnestad R, Løberg EM, Bonnier ML, Buljovcic VB, Johansson KA, Fadnes LT; INTRO-HCV Study Group. Lygren OJ, et al. Subst Abuse Treat Prev Policy. 2019 Dec 21;14(1):58. doi: 10.1186/s13011-019-0245-y. Subst Abuse Treat Prev Policy. 2019. PMID: 31864396 Free PMC article.
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).
Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA; INTRO-HCV Study Group. Fadnes LT, et al. Among authors: leiva ra. PLoS Med. 2021 Jun 1;18(6):e1003653. doi: 10.1371/journal.pmed.1003653. eCollection 2021 Jun. PLoS Med. 2021. PMID: 34061883 Free PMC article. Clinical Trial.
High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway.
Leiva RA, Bergersen BM, Finbråten AK, Sandvei PK, Simonsen Ø, Rosseland CM, Hagen K, Young L, Roberts RS, Mikkelsen Y, Singh R, Lagging M, Dalgard O. Leiva RA, et al. Scand J Gastroenterol. 2023 Mar;58(3):264-268. doi: 10.1080/00365521.2022.2118555. Epub 2022 Sep 5. Scand J Gastroenterol. 2023. PMID: 36063075
27 results